FEB 04, 2016 4:14 PM PST

Sharpin Protein Necessary for T Regulatory Cell Function

WRITTEN BY: Kara Marker
The body needs regulatory T cells (Tregs) on the sidelines of an immune attack, making sure tempers don’t run too hot and preventing the body’s lymphocytes from taking the body’s own cells. Because of this vital role, scientist strive to pinpoint the key mechanisms for Treg function and survival. The newest research calls on Sharpin, formally known as SHANK-Associated RH Domain Interactor, a protein involved linear polyubiquitination and associated with “inappropriate inflammation” (Gene Cards)
 
From the La Jolla Institute for Allergy and Immunology, Yun-Cai Liu, PhD, and his team set out to decipher definitively the relationship between Sharpin and Tregs. Their study was published in Nature Immunology earlier this month.
 
"Treg-based intervention has in fact been proposed as a novel therapeutic means to treat various inflammatory diseases, meaning that knowing how Treg function is regulated could speed development of effective treatments,” said study co-author Hyung-seung Jin.
 


To study the functionality of Tregs, the researchers observed mice that lacked any Sharpin protein. Not long after being born, the Sharpin knock-out mice developed skin lesions and internal inflammation, despite being free of any infections. The last clue was the low Treg cell count in all tissues, even in the thymus where all T lymphocytes develop. These outcomes strongly linked a lack of Sharpin to low numbers of Tregs, which resulted as expected in unnecessary inflammatory responses.
 
The team also replenished the Treg population in the knock-out mice by injecting healthy Tregs from normal mice who were born with Sharpin. They saw a clear reduction in inflammation severity.
 
Without the “cell survival mechanism” provided by Sharpin during Treg development, the lymphocytes die in the thymus. A single mutation in the genes coding for Sharpin could lead to autoimmune disease. Now scientists will know to check for Sharpin proteins in cases of autoimmune disease where Treg levels are low all over the body. If a lack of Sharpin ends up being the cause of disease, a treatment of healthy Tregs with ample Sharpin to keep them alive, similar to the replenishment done in this study, could potentially help people with autoimmune disease.
 
Also promising are the applications for cancer treatments made possible with this discovery. Scientists could carefully take advantage of Treg dependence on Sharpin for survival when fighting tumors in certain tissues. By limiting Sharpin production in certain tissues, killer lymphocytes like cytotoxic T cells could experience enhanced tumor recognition and attack more efficiently, behaviors which are usually heavily monitored and inhibited by Tregs.
 
 
Source: La Jolla Institute for Allergy and Immunology
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 20, 2021
Coronavirus
Pregnant and lactating people can pass COVID-19 antibodies from the vaccine
JUL 20, 2021
Pregnant and lactating people can pass COVID-19 antibodies from the vaccine
New research found that both pregnant and lactating people who receive the COVID-19 vaccine can pass antibodies to their ...
JUL 29, 2021
Immunology
Scientists Discover Bacterial Life on Human Fetuses
JUL 29, 2021
Scientists Discover Bacterial Life on Human Fetuses
A developing fetus in its second trimester of life is changing at an extraordinarily rapid pace––bones are b ...
AUG 23, 2021
Microbiology
During a Chronic Viral Infection, Immune Cells May Suffer 'Exhaustion'
AUG 23, 2021
During a Chronic Viral Infection, Immune Cells May Suffer 'Exhaustion'
Several viruses are known to cause chronic infections, one is hepatitis C virus (HCV). Researchers studying these infect ...
AUG 25, 2021
Cell & Molecular Biology
Sino Biological's Listing on the Shenzhen Stock Exchange
AUG 25, 2021
Sino Biological's Listing on the Shenzhen Stock Exchange
China, August 16, 2021 - Sino Biological, Inc. (“Sino Biological” or the “Company”), a biot ...
SEP 02, 2021
Immunology
Hobit Activates Cancer-Killing Immune Cells
SEP 02, 2021
Hobit Activates Cancer-Killing Immune Cells
Innate lymphoid cells, or ILCs, are specialized immune cells that are increasingly entering the research spotlight. Thes ...
SEP 14, 2021
Drug Discovery & Development
A novel drug that targets the removal of pathogenic antibodies in myasthenia gravis
SEP 14, 2021
A novel drug that targets the removal of pathogenic antibodies in myasthenia gravis
Myasthenia gravis is a chronic autoimmune disorder characterized by muscle weakness and fatigue. The disorder leads to a ...
Loading Comments...